Veterans Health Administration, North-Western Iowa VAMC, 4101 Woolworth Ave, Medicine Dept 111, Omaha, NE 68105, USA.
Crit Care Nurs Clin North Am. 2022 Sep;34(3):331-339. doi: 10.1016/j.cnc.2022.04.011.
This article aims to focus on identifying hepatic encephalopathy (HE) due to portal hypertension and cirrhosis and implementing the most appropriate treatment. The occurrence of hepatic encephalopathy is prognostic in the life expectancy and quality of life of individuals with cirrhosis. Patients diagnosed with cirrhosis should be thoroughly assessed for HE. Many studies have identified that even HE in a subclinical (covert) presentation is a predicator of increased mortality before and after liver transplant. HE, rather minimal or overt, indicates diminished quality of life and increased health care dollars and mortality.
本文旨在重点关注识别门静脉高压和肝硬化引起的肝性脑病（HE）并实施最恰当的治疗。HE 的发生对肝硬化患者的预期寿命和生活质量具有预后意义。诊断为肝硬化的患者应彻底评估 HE。许多研究表明，即使是亚临床（隐匿性）表现的 HE 也是肝移植前后死亡率增加的预测因子。HE 无论轻微还是明显，都表明生活质量下降，医疗保健费用增加和死亡率增加。
